Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tawanda Gumbo

Showing results (111-120 of 204) with videos related to

Pageof 21
Sort By:
Frontiers in Pharmacology|June 24, 2021
Cefdinir and β-Lactamase Inhibitor Independent Efficacy Against <i>Mycobacterium tuberculosis</i>Shashikant Srivastava, Tania Thomas, Dave Howe, et al.
Antimicrobial Agents and Chemotherapy|December 22, 2023
Omadacycline pharmacokinetics/pharmacodynamics and efficacy against multidrug-resistant <i>Mycobacterium tuberculosis</i> in the hollow fiber system modelSanjay Singh, Tawanda Gumbo, Gunavanthi D Boorgula, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2015
Amikacin Concentrations Predictive of Ototoxicity in Multidrug-Resistant Tuberculosis PatientsChawangwa Modongo, Jotam G Pasipanodya, Nicola M Zetola, et al.
Tuberculosis (Edinburgh, Scotland)|May 16, 2024
Omadacycline drug susceptibility testing for non-tuberculous mycobacteria using oxyrase to overcome challenges with drug degradationGunavanthi D Boorgula, Tawanda Gumbo, Sanjay Singh, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2023
Optimizing anidulafungin exposure across a wide adult body size rangeRonald G Hall, Shuhan Liu, William C Putnam, et al.
The Journal of Infectious Diseases|October 13, 2004
Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modelingTawanda Gumbo, Arnold Louie, Mark R Deziel, et al.
Diagnostic Microbiology and Infectious Disease|November 21, 2007
Population pharmacokinetics of micafungin in adult patientsTawanda Gumbo, John Hiemenz, Lei Ma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2018
The Sterilizing Effect of Intermittent Tedizolid for Pulmonary TuberculosisShashikant Srivastava, Devyani Deshpande, Eric Nuermberger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2016
Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First StepsDevyani Deshpande, Shashikant Srivastava, Jotam G Pasipanodya, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2017
Systematic Review and Meta-analyses of the Effect of Chemotherapy on Pulmonary Mycobacterium abscessus Outcomes and Disease RecurrenceJotam G Pasipanodya, Deborah Ogbonna, Beatriz E Ferro, et al.
Pageof 21

Showing results (111-120 of 204) with videos related to

Sort By:
Pageof 21
Frontiers in Pharmacology|June 24, 2021
Cefdinir and β-Lactamase Inhibitor Independent Efficacy Against <i>Mycobacterium tuberculosis</i>Shashikant Srivastava, Tania Thomas, Dave Howe, et al.
Antimicrobial Agents and Chemotherapy|December 22, 2023
Omadacycline pharmacokinetics/pharmacodynamics and efficacy against multidrug-resistant <i>Mycobacterium tuberculosis</i> in the hollow fiber system modelSanjay Singh, Tawanda Gumbo, Gunavanthi D Boorgula, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2015
Amikacin Concentrations Predictive of Ototoxicity in Multidrug-Resistant Tuberculosis PatientsChawangwa Modongo, Jotam G Pasipanodya, Nicola M Zetola, et al.
Tuberculosis (Edinburgh, Scotland)|May 16, 2024
Omadacycline drug susceptibility testing for non-tuberculous mycobacteria using oxyrase to overcome challenges with drug degradationGunavanthi D Boorgula, Tawanda Gumbo, Sanjay Singh, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2023
Optimizing anidulafungin exposure across a wide adult body size rangeRonald G Hall, Shuhan Liu, William C Putnam, et al.
The Journal of Infectious Diseases|October 13, 2004
Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modelingTawanda Gumbo, Arnold Louie, Mark R Deziel, et al.
Diagnostic Microbiology and Infectious Disease|November 21, 2007
Population pharmacokinetics of micafungin in adult patientsTawanda Gumbo, John Hiemenz, Lei Ma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2018
The Sterilizing Effect of Intermittent Tedizolid for Pulmonary TuberculosisShashikant Srivastava, Devyani Deshpande, Eric Nuermberger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2016
Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First StepsDevyani Deshpande, Shashikant Srivastava, Jotam G Pasipanodya, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2017
Systematic Review and Meta-analyses of the Effect of Chemotherapy on Pulmonary Mycobacterium abscessus Outcomes and Disease RecurrenceJotam G Pasipanodya, Deborah Ogbonna, Beatriz E Ferro, et al.
Pageof 21